Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Multifaceted Understandings of Cancer: A Review of Disease Mechanisms and Therapies

Author(s): Rashmi Saxena Pal*, Yogendra Pal, Motamarri Venkata Naga Lalitha Chaitanya, Ravindra Babu, Rupa Mazumder and Arvind Kumar

Volume 20, Issue 5, 2024

Published on: 16 October, 2023

Page: [481 - 488] Pages: 8

DOI: 10.2174/0115733947261646231006045929

Price: $65

conference banner
Abstract

Cancer is a condition in which aberrant cells continue to divide uncontrollably, causing tissue to be destroyed. Different cancer stages have been identified by researchers, suggesting that a number of gene alterations are involved in the etiology of cancer. Unusual cell proliferation is brought on by these gene alterations. A crucial role in the acceleration of cell proliferation is played by genetic diseases brought on by heredity or hereditary factors. Its diagnosis and treatment have historically been regarded as two of the most important and significant clinical concerns. Depending on the nature and stage of the tumor, numerous ways to its corrective therapy have been established. Numerous biomolecules derived from plants are crucial for the treatment of the disease. In this review, we focus on specific aspects to give a brief overview of the major problems, including their etiology, therapies that are available, herbal alternates, available vaccines and relevant biomarkers. It was felt that much work needs to be done on combination therapy development and platform optimization.

« Previous Next »
Graphical Abstract

[1]
Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin., 2013, 63(1), 11-30.
[http://dx.doi.org/10.3322/caac.21166] [PMID: 23335087]
[2]
Kamps, R.; Brandão, R.; Bosch, B. Next-generation sequencing in oncology: Genetic diagnosis, risk prediction and cancer classification. Int. J. Mol. Sci., 2017, 18(2), 308.
[http://dx.doi.org/10.3390/ijms18020308] [PMID: 28146134]
[3]
Petrucelli, N.; Daly, M.B.; Pal, T. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer.GeneReviews®. Seattle, WA: University of Washington, Seattle 1998; pp. 1993-2023. Avialable from: https://www.ncbi.nlm.nih.gov/books/NBK1247/ (Updated 2022 May 26).
[4]
Weiss, C. One in four dies of cancer. questions about the epidemiology of malignant tumours. Recent Results Cancer Res., 2021, 218, 15-29.
[http://dx.doi.org/10.1007/978-3-030-63749-1_2] [PMID: 34019159]
[5]
Anand, P.; Kunnumakara, A.B.; Sundaram, C. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res., 2008, 25(9), 2097-2116.
[http://dx.doi.org/10.1007/s11095-008-9661-9] [PMID: 18626751]
[6]
Parsa, N. Environmental factors inducing human cancers. Iran. J. Public Health, 2012, 41(11), 1-9.
[PMID: 23304670]
[7]
Lee, E.Y.H.P.; Muller, W.J. Oncogenes and tumor suppressor genes. Cold Spring Harb. Perspect. Biol., 2010, 2(10), a003236.
[http://dx.doi.org/10.1101/cshperspect.a003236] [PMID: 20719876]
[8]
Kinghorn, A.D.; Chin, Y.W.; Swanson, S.M. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Devel., 2009, 12(2), 189-196.
[PMID: 19333864]
[9]
Cragg, G.M.; Newman, D.J. A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J. Nat. Prod., 2004, 67(2), 232-244.
[http://dx.doi.org/10.1021/np030420c] [PMID: 14987065]
[10]
Torgovnick, A.; Schumacher, B. DNA repair mechanisms in cancer development and therapy. Front. Genet., 2015, 6, 157.
[http://dx.doi.org/10.3389/fgene.2015.00157] [PMID: 25954303]
[11]
Testa, U.; Pelosi, E.; Castelli, G. Colorectal cancer: Genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med. Sci., 2018, 6(2), 31.
[http://dx.doi.org/10.3390/medsci6020031] [PMID: 29652830]
[12]
Mesin, L.; Ersching, J.; Victora, G.D. Germinal center B cell dynamics. Immunity, 2016, 45(3), 471-482.
[http://dx.doi.org/10.1016/j.immuni.2016.09.001] [PMID: 27653600]
[13]
Thatte, U.; Dhahanukar, S. Ayurveda, the natural alternative. Sci Today, 1991, 2001, 12-18.
[14]
Loeb, L.A.; Loeb, K.R.; Anderson, J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci., 2003, 100(3), 776-781.
[http://dx.doi.org/10.1073/pnas.0334858100] [PMID: 12552134]
[15]
Rivlin, N.; Brosh, R.; Oren, M.; Rotter, V. Mutations in the p53 tumor suppressor gene: Important milestones at the various steps of tumorigenesis. Genes Cancer, 2011, 2(4), 466-474.
[http://dx.doi.org/10.1177/1947601911408889] [PMID: 21779514]
[16]
Smit, H.F.; Woerdenbag, H.J.; Singh, R.H.; Meulenbeld, G.J.; Labadie, R.P.; Zwaving, J.H. Āyurvedic herbal drugs with possible cytostatic activity. J. Ethnopharmacol., 1995, 47(2), 75-84.
[http://dx.doi.org/10.1016/0378-8741(95)01255-C] [PMID: 7500639]
[17]
Cravotto, G.; Boffa, L.; Genzini, L.; Garella, D. Phytotherapeutics: An evaluation of the potential of 1000 plants. J. Clin. Pharm. Ther., 2010, 35(1), 11-48.
[http://dx.doi.org/10.1111/j.1365-2710.2009.01096.x] [PMID: 20175810]
[18]
Patel, B.; Das, S.; Prakash, R.; Yasir, M. Natural bioactive compound with anticancer potential. Int J Adv Pharmac Sci, 2010, 1(1), 32-41.
[http://dx.doi.org/10.5138/ijaps.2010.0976.1055.01003]
[19]
Sergides, C.; Chirilă, M.; Silvestro, L.; Pitta, D.; Pittas, A. Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp. Ther. Med., 2016, 11(1), 164-170.
[http://dx.doi.org/10.3892/etm.2015.2895] [PMID: 26889234]
[20]
Balachandran, P.; Govindarajan, R. Cancer: An ayurvedic perspective. Pharmacol. Res., 2005, 51(1), 19-30.
[http://dx.doi.org/10.1016/j.phrs.2004.04.010] [PMID: 15519531]
[21]
Kosta, S.; Tiwari, A.; Jain, R. Ayurveda and cancer. Pharmacognosy Res., 2010, 2(6), 393-394.
[http://dx.doi.org/10.4103/0974-8490.75463] [PMID: 21713145]
[22]
Woodyard, C. Exploring the therapeutic effects of yoga and its ability to increase quality of life. Int. J. Yoga, 2011, 4(2), 49-54.
[http://dx.doi.org/10.4103/0973-6131.85485] [PMID: 22022122]
[23]
Wang, H.; Oo Khor, T.; Shu, L. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer. Agents Med. Chem., 2012, 12(10), 1281-1305.
[http://dx.doi.org/10.2174/187152012803833026] [PMID: 22583408]
[24]
Dhruva, A.; Hecht, F.M.; Miaskowski, C. Correlating traditional Ayurvedic and modern medical perspectives on cancer: Results of a qualitative study. J. Altern. Complement. Med., 2014, 20(5), 364-370.
[http://dx.doi.org/10.1089/acm.2013.0259] [PMID: 24341342]
[25]
Sharma, P.; Kajaria, D. Role of Kalpa Chikitsa in the management of Lynch syndrome: A case report. J. Family Med. Prim. Care, 2020, 9(5), 2487-2491.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_161_20] [PMID: 32754525]
[26]
Arruebo, M.; Vilaboa, N.; Sáez-Gutierrez, B. Assessment of the evolution of cancer treatment therapies. Cancers , 2011, 3(3), 3279-3330.
[http://dx.doi.org/10.3390/cancers3033279] [PMID: 24212956]
[27]
Dos Santos, A.F.; De Almeida, D.R.Q.; Terra, L.F.; Baptista, M.S.; Labriola, L. Photodynamic therapy in cancer treatment: An update review. J. Cancer Metastasis Treat., 2019, 2019, 25.
[http://dx.doi.org/10.20517/2394-4722.2018.83]
[28]
Cooper GM. The Cell: A Molecular Approach. Sunderland (MA): Sinauer Associates 2000. Avialable from: https://www.ncbi.nlm.nih.gov/books/NBK9963/
[29]
Marusyk, A.; Polyak, K. Tumor heterogeneity: Causes and consequences. Biochim. Biophys. Acta Rev. Cancer, 2010, 1805(1), 105-117.
[http://dx.doi.org/10.1016/j.bbcan.2009.11.002] [PMID: 19931353]
[30]
Greaves, M.; Maley, C.C. Clonal evolution in cancer. Nature, 2012, 481(7381), 306-313.
[http://dx.doi.org/10.1038/nature10762] [PMID: 22258609]
[31]
Abdel-Rahman, S.Z.; El-Zein, R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett., 2000, 159(1), 63-71.
[http://dx.doi.org/10.1016/S0304-3835(00)00532-2] [PMID: 10974407]
[32]
Adjei, A.A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst., 2001, 93(14), 1062-1074.
[http://dx.doi.org/10.1093/jnci/93.14.1062] [PMID: 11459867]
[33]
Goossens, N.; Nakagawa, S.; Sun, X.; Hoshida, Y. Cancer biomarker discovery and validation. Transl. Cancer Res., 2015, 4(3), 256-269.
[http://dx.doi.org/10.3978/j.issn.2218-676X.2015.06.04] [PMID: 26213686]
[34]
Sankar, S.; Nayanar, S.K.; Balasubramanian, S. Current trends in cancer vaccines: A bioinformatics perspective. Asian Pac. J. Cancer Prev., 2013, 14(7), 4041-4047.
[http://dx.doi.org/10.7314/APJCP.2013.14.7.4041] [PMID: 23991949]
[35]
Saxena, M.; van der Burg, S.H.; Melief, C.J.M.; Bhardwaj, N. Therapeutic cancer vaccines. Nat. Rev. Cancer, 2021, 21(6), 360-378.
[http://dx.doi.org/10.1038/s41568-021-00346-0] [PMID: 33907315]
[36]
Desai, A.; Qazi, G.; Ganju, R. Medicinal plants and cancer chemoprevention. Curr. Drug Metab., 2008, 9(7), 581-591.
[http://dx.doi.org/10.2174/138920008785821657] [PMID: 18781909]
[37]
Baskar, R.; Lee, K.A.; Yeo, R.; Yeoh, K.W. Cancer and radiation therapy: Current advances and future directions. Int. J. Med. Sci., 2012, 9(3), 193-199.
[http://dx.doi.org/10.7150/ijms.3635] [PMID: 22408567]
[38]
Debela, D.T.; Muzazu, S.G.Y.; Heraro, K.D. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med., 2021, 9.
[http://dx.doi.org/10.1177/20503121211034366] [PMID: 34408877]
[39]
Bondhopadhyay, B.; Sisodiya, S.; Chikara, A. Cancer immunotherapy: A promising dawn in cancer research. Am. J. Blood Res., 2020, 10(6), 375-385.
[PMID: 33489447]
[40]
Barnes, D.W.H.; Corp, M.J.; Loutit, J.F.; Neal, F.E. Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication. BMJ, 1956, 2(4993), 626-627.
[http://dx.doi.org/10.1136/bmj.2.4993.626] [PMID: 13356034]
[41]
Sarhadi, V.K.; Armengol, G. Molecular biomarkers in cancer. Biomolecules, 2022, 12(8), 1021.
[http://dx.doi.org/10.3390/biom12081021] [PMID: 35892331]
[42]
Akras, Z.; Bungo, B.; Leach, B.H. Primer on hereditary cancer predisposition genes included within somatic next-generation sequencing panels. JCO Precis. Oncol., 2019, 3(3), 1-11.
[http://dx.doi.org/10.1200/PO.18.00258] [PMID: 35100683]
[43]
Behrouzkia, Z.; Joveini, Z.; Keshavarzi, B.; Eyvazzadeh, N.; Aghdam, R.Z. Hyperthermia: How can it be used? Oman Med. J., 2016, 31(2), 89-97.
[http://dx.doi.org/10.5001/omj.2016.19] [PMID: 27168918]
[44]
Kou, J.; Dou, D.; Yang, L. Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget, 2017, 8(46), 81591-81603.
[http://dx.doi.org/10.18632/oncotarget.20189] [PMID: 29113417]
[45]
Agostinis, P.; Berg, K.; Cengel, K.A. Photodynamic therapy of cancer: An update. CA Cancer J. Clin., 2011, 61(4), 250-281.
[http://dx.doi.org/10.3322/caac.20114] [PMID: 21617154]
[46]
Altun, İ.; Sonkaya, A. The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran. J. Public Health, 2018, 47(8), 1218-1219.
[PMID: 30186799]
[47]
Wochna Loerzel, V. Symptom experience in older adults undergoing treatment for cancer. Oncol. Nurs. Forum, 2015, 42(3), E269-E278.
[http://dx.doi.org/10.1188/15.ONF.E269-E278] [PMID: 25901389]
[48]
Henry, N.L.; Hayes, D.F. Cancer biomarkers. Mol. Oncol., 2012, 6(2), 140-146.
[http://dx.doi.org/10.1016/j.molonc.2012.01.010] [PMID: 22356776]
[49]
Allred, D.C. Commentary: Hormone receptor testing in breast cancer: A distress signal from Canada. Oncologist, 2008, 13(11), 1134-1136.
[http://dx.doi.org/10.1634/theoncologist.2008-0184] [PMID: 18987048]
[50]
Zahavi, D.; Weiner, L. Monoclonal antibodies in cancer therapy. Antibodies , 2020, 9(3), 34.
[http://dx.doi.org/10.3390/antib9030034] [PMID: 32698317]
[51]
Malonis, R.J.; Lai, J.R.; Vergnolle, O. Peptide-based vaccines: Current progress and future challenges. Chem. Rev., 2020, 120(6), 3210-3229.
[http://dx.doi.org/10.1021/acs.chemrev.9b00472] [PMID: 31804810]
[52]
Buonaguro, L.; Tagliamonte, M. Selecting target antigens for cancer vaccine development. Vaccines , 2020, 8(4), 615.
[http://dx.doi.org/10.3390/vaccines8040615] [PMID: 33080888]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy